| Dr Erik A Cooper, DO | |
|
7926 Tennyson Ct, Boca Raton, FL 33433 | |
| (412) 728-4256 | |
| Not Available |
| Full Name | Dr Erik A Cooper |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 19 Years |
| Location | 7926 Tennyson Ct, Boca Raton, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124282199 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | OS014646 (Pennsylvania) | Secondary |
| 207L00000X | Anesthesiology | 34.011794 (Ohio) | Primary |
| 207L00000X | Anesthesiology | OS12287 (Florida) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mount Carmel East & West | Columbus, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Premier Anesthesia Of Ohio Llc | 3779714258 | 85 |
News Archive
German health authorities have reported to WHO an imported case of Lassa fever, confirmed by laboratory tests at the Bernhard-Nocht-Institute of Tropical Medicine, Hamburg, Germany.
WPS Health Insurance, Wisconsin's leading not-for-profit health insurer, has been recognized by the Ethisphere Institute as one of the World's Most Ethical Companies for 2010. Out of a record number of nominations for the award, WPS Health Insurance (Wisconsin Physicians Service) secured a hard-earned spot on the list by going the extra mile, implementing upright business practices and initiatives that are instrumental to the company's success, benefit the community, and raise the bar for ethical standards within the industry.
Visterra, Inc., a developer of novel antibody therapeutics to prevent and treat major infectious diseases, today announced that it has secured an exclusive patent license from Massachusetts Institute of Technology to a family of early-stage monoclonal antibodies that target dengue virus. These antibodies were developed by MIT in the laboratory of Dr. Ram Sasisekharan, a founder of Visterra, using novel protein engineering approaches. Visterra will apply its proprietary network analysis technology to develop a human monoclonal antibody product candidate capable of broadly neutralizing all four dengue virus serotypes.
Exposure to lead during early development can alter the the gut microbiota, increasing the chances for obesity in adulthood, researchers from the University of Michigan School of Public Health have found.
A new study published today in the journal Applied Physiology, Nutrition, and Metabolism looks beyond the much-feared weight gain common to first-year students and reports on the full 4-year impact of higher education on weight, BMI, and body composition.
› Verified 7 days ago
| Entity Name | Lima Memorial Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457474900 PECOS PAC ID: 1254232184 Enrollment ID: O20040115000131 |
News Archive
German health authorities have reported to WHO an imported case of Lassa fever, confirmed by laboratory tests at the Bernhard-Nocht-Institute of Tropical Medicine, Hamburg, Germany.
WPS Health Insurance, Wisconsin's leading not-for-profit health insurer, has been recognized by the Ethisphere Institute as one of the World's Most Ethical Companies for 2010. Out of a record number of nominations for the award, WPS Health Insurance (Wisconsin Physicians Service) secured a hard-earned spot on the list by going the extra mile, implementing upright business practices and initiatives that are instrumental to the company's success, benefit the community, and raise the bar for ethical standards within the industry.
Visterra, Inc., a developer of novel antibody therapeutics to prevent and treat major infectious diseases, today announced that it has secured an exclusive patent license from Massachusetts Institute of Technology to a family of early-stage monoclonal antibodies that target dengue virus. These antibodies were developed by MIT in the laboratory of Dr. Ram Sasisekharan, a founder of Visterra, using novel protein engineering approaches. Visterra will apply its proprietary network analysis technology to develop a human monoclonal antibody product candidate capable of broadly neutralizing all four dengue virus serotypes.
Exposure to lead during early development can alter the the gut microbiota, increasing the chances for obesity in adulthood, researchers from the University of Michigan School of Public Health have found.
A new study published today in the journal Applied Physiology, Nutrition, and Metabolism looks beyond the much-feared weight gain common to first-year students and reports on the full 4-year impact of higher education on weight, BMI, and body composition.
› Verified 7 days ago
| Entity Name | Dayton Anesthesia & Pain Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629401898 PECOS PAC ID: 8022245372 Enrollment ID: O20131212001655 |
News Archive
German health authorities have reported to WHO an imported case of Lassa fever, confirmed by laboratory tests at the Bernhard-Nocht-Institute of Tropical Medicine, Hamburg, Germany.
WPS Health Insurance, Wisconsin's leading not-for-profit health insurer, has been recognized by the Ethisphere Institute as one of the World's Most Ethical Companies for 2010. Out of a record number of nominations for the award, WPS Health Insurance (Wisconsin Physicians Service) secured a hard-earned spot on the list by going the extra mile, implementing upright business practices and initiatives that are instrumental to the company's success, benefit the community, and raise the bar for ethical standards within the industry.
Visterra, Inc., a developer of novel antibody therapeutics to prevent and treat major infectious diseases, today announced that it has secured an exclusive patent license from Massachusetts Institute of Technology to a family of early-stage monoclonal antibodies that target dengue virus. These antibodies were developed by MIT in the laboratory of Dr. Ram Sasisekharan, a founder of Visterra, using novel protein engineering approaches. Visterra will apply its proprietary network analysis technology to develop a human monoclonal antibody product candidate capable of broadly neutralizing all four dengue virus serotypes.
Exposure to lead during early development can alter the the gut microbiota, increasing the chances for obesity in adulthood, researchers from the University of Michigan School of Public Health have found.
A new study published today in the journal Applied Physiology, Nutrition, and Metabolism looks beyond the much-feared weight gain common to first-year students and reports on the full 4-year impact of higher education on weight, BMI, and body composition.
› Verified 7 days ago
| Entity Name | Premier Anesthesia Of Ohio Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699196022 PECOS PAC ID: 3779714258 Enrollment ID: O20140326001267 |
News Archive
German health authorities have reported to WHO an imported case of Lassa fever, confirmed by laboratory tests at the Bernhard-Nocht-Institute of Tropical Medicine, Hamburg, Germany.
WPS Health Insurance, Wisconsin's leading not-for-profit health insurer, has been recognized by the Ethisphere Institute as one of the World's Most Ethical Companies for 2010. Out of a record number of nominations for the award, WPS Health Insurance (Wisconsin Physicians Service) secured a hard-earned spot on the list by going the extra mile, implementing upright business practices and initiatives that are instrumental to the company's success, benefit the community, and raise the bar for ethical standards within the industry.
Visterra, Inc., a developer of novel antibody therapeutics to prevent and treat major infectious diseases, today announced that it has secured an exclusive patent license from Massachusetts Institute of Technology to a family of early-stage monoclonal antibodies that target dengue virus. These antibodies were developed by MIT in the laboratory of Dr. Ram Sasisekharan, a founder of Visterra, using novel protein engineering approaches. Visterra will apply its proprietary network analysis technology to develop a human monoclonal antibody product candidate capable of broadly neutralizing all four dengue virus serotypes.
Exposure to lead during early development can alter the the gut microbiota, increasing the chances for obesity in adulthood, researchers from the University of Michigan School of Public Health have found.
A new study published today in the journal Applied Physiology, Nutrition, and Metabolism looks beyond the much-feared weight gain common to first-year students and reports on the full 4-year impact of higher education on weight, BMI, and body composition.
› Verified 7 days ago
| Entity Name | Sandusky Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770907859 PECOS PAC ID: 3274895271 Enrollment ID: O20180402000752 |
News Archive
German health authorities have reported to WHO an imported case of Lassa fever, confirmed by laboratory tests at the Bernhard-Nocht-Institute of Tropical Medicine, Hamburg, Germany.
WPS Health Insurance, Wisconsin's leading not-for-profit health insurer, has been recognized by the Ethisphere Institute as one of the World's Most Ethical Companies for 2010. Out of a record number of nominations for the award, WPS Health Insurance (Wisconsin Physicians Service) secured a hard-earned spot on the list by going the extra mile, implementing upright business practices and initiatives that are instrumental to the company's success, benefit the community, and raise the bar for ethical standards within the industry.
Visterra, Inc., a developer of novel antibody therapeutics to prevent and treat major infectious diseases, today announced that it has secured an exclusive patent license from Massachusetts Institute of Technology to a family of early-stage monoclonal antibodies that target dengue virus. These antibodies were developed by MIT in the laboratory of Dr. Ram Sasisekharan, a founder of Visterra, using novel protein engineering approaches. Visterra will apply its proprietary network analysis technology to develop a human monoclonal antibody product candidate capable of broadly neutralizing all four dengue virus serotypes.
Exposure to lead during early development can alter the the gut microbiota, increasing the chances for obesity in adulthood, researchers from the University of Michigan School of Public Health have found.
A new study published today in the journal Applied Physiology, Nutrition, and Metabolism looks beyond the much-feared weight gain common to first-year students and reports on the full 4-year impact of higher education on weight, BMI, and body composition.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Erik A Cooper, DO 2139 Auburn Ave, Cincinnati, OH 45219-2906 Ph: (412) 728-4256 | Dr Erik A Cooper, DO 7926 Tennyson Ct, Boca Raton, FL 33433 Ph: (412) 728-4256 |
News Archive
German health authorities have reported to WHO an imported case of Lassa fever, confirmed by laboratory tests at the Bernhard-Nocht-Institute of Tropical Medicine, Hamburg, Germany.
WPS Health Insurance, Wisconsin's leading not-for-profit health insurer, has been recognized by the Ethisphere Institute as one of the World's Most Ethical Companies for 2010. Out of a record number of nominations for the award, WPS Health Insurance (Wisconsin Physicians Service) secured a hard-earned spot on the list by going the extra mile, implementing upright business practices and initiatives that are instrumental to the company's success, benefit the community, and raise the bar for ethical standards within the industry.
Visterra, Inc., a developer of novel antibody therapeutics to prevent and treat major infectious diseases, today announced that it has secured an exclusive patent license from Massachusetts Institute of Technology to a family of early-stage monoclonal antibodies that target dengue virus. These antibodies were developed by MIT in the laboratory of Dr. Ram Sasisekharan, a founder of Visterra, using novel protein engineering approaches. Visterra will apply its proprietary network analysis technology to develop a human monoclonal antibody product candidate capable of broadly neutralizing all four dengue virus serotypes.
Exposure to lead during early development can alter the the gut microbiota, increasing the chances for obesity in adulthood, researchers from the University of Michigan School of Public Health have found.
A new study published today in the journal Applied Physiology, Nutrition, and Metabolism looks beyond the much-feared weight gain common to first-year students and reports on the full 4-year impact of higher education on weight, BMI, and body composition.
› Verified 7 days ago
Anthony Riso, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 771 Ne 33rd St, Boca Raton, FL 33431 Phone: 561-247-1020 Fax: 954-510-2060 | |
Dr. Juan P Giraldo, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 660 Glades Rd, Suite 460, Boca Raton, FL 33431 Phone: 561-391-5515 Fax: 561-347-7470 | |
Dr. Kenneth Lawrence Ross, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 785 Ne 33rd St, Boca Raton, FL 33431 Phone: 561-750-1130 Fax: 561-750-1130 | |
George R Luck, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 800 Meadows Rd, Boca Raton, FL 33486 Phone: 561-395-7100 | |
Azra Khan, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 7100 W Camino Real, Suite 301, Boca Raton, FL 33433 Phone: 772-924-2527 | |
Dr. David Lee Dresner, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 22503 Esplanada Cir W, Boca Raton, FL 33433 Phone: 561-562-7755 |